NEXGEL, INC. Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss
NEXGEL, INC. (NXGL) reported Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss of $68.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Income Statement › Other Income
us-gaap:MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments · last filed 2026-03-31
- NEXGEL, INC. marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2024-06-30 was $23.00K.
- NEXGEL, INC. marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2024-03-31 was $34.00K, a 385.71% increase year-over-year.
- NEXGEL, INC. marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2023-03-31 was $7.00K.
- NEXGEL, INC. marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2022-12-31 was $4.00K.
- NEXGEL, INC. marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for fiscal 2024 was $68.00K, a 64.40% decline from fiscal 2023.
- NEXGEL, INC. marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for fiscal 2023 was $191.00K, a 2022.22% increase from fiscal 2022.
- NEXGEL, INC. marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for fiscal 2022 was $9.00K.
| Period end | Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss 3 month | Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss 6 month | Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss 9 month | Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss 12 month |
|---|---|---|---|---|
| 2024-12-31 | $68.00K 10-K · filed 2026-03-31 | |||
| 2024-06-30 | $23.00K 10-Q · filed 2025-08-12 | $57.00K 10-Q · filed 2025-08-12 | ||
| 2024-03-31 | $34.00K 10-Q · filed 2025-05-13 | |||
| 2023-12-31 | $191.00K 10-K · filed 2025-03-27 | |||
| 2023-03-31 | $7.00K 10-Q · filed 2024-05-13 | $11.00K derived: sum of 2 quarters · filed 2024-05-13 | $16.00K derived: sum of 3 quarters · filed 2024-05-13 | |
| 2022-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-10 | $9.00K derived: sum of 2 quarters · filed 2024-04-10 | $9.00K 10-K · filed 2024-04-10 | |
| 2022-09-30 | $5.00K 10-Q · filed 2022-11-08 | $5.00K 10-Q · filed 2022-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |